Howard G Wildman

Title: Howard G Wildman: Innovator in Biochemical Compounds

Introduction

Howard G Wildman is a notable inventor based in Greenford, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have potential therapeutic applications. With a total of 2 patents, Wildman has focused on innovations that can impact health and medicine.

Latest Patents

Wildman's latest patents include the development of cyclic ketal derivatives. These compounds are described by a specific formula where various groups can represent hydrogen atoms, hydroxyl groups, or other complex structures. The primary focus of these compounds is to inhibit the enzyme squalene synthase, which plays a crucial role in cholesterol synthesis. Additionally, these compounds may serve as intermediates for preparing other compounds that inhibit the same enzyme. The applications of these inventions are significant, as they can be formulated for conditions where lowering blood plasma cholesterol is beneficial and for combating fungal infections in animals.

Career Highlights

Howard G Wildman is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work there has allowed him to contribute to groundbreaking research and development in biochemistry. His innovative approach has led to advancements that could potentially improve health outcomes.

Collaborations

Throughout his career, Wildman has collaborated with notable colleagues, including Michael John Dawson and Nigel Stephen Watson. These collaborations have fostered an environment of innovation and have contributed to the success of their projects.

Conclusion

Howard G Wildman is a distinguished inventor whose work in cyclic ketal derivatives showcases his commitment to advancing biochemistry. His contributions have the potential to make a significant impact on health and medicine.